United States · FDA National Drug Code directory

CAPTOPRIL AND HYDROCHLOROTHIAZIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 16571-828_0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e
Product NDC: 16571-828
Form: TABLET
Composition / generic term: CAPTOPRIL AND HYDROCHLOROTHIAZIDE
Labeler: Rising Pharma Holdings, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20230214
Source listing expiry: 20261231

Source-listed ingredients

CAPTOPRIL — 25 mg/1
HYDROCHLOROTHIAZIDE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

90 TABLET in 1 BOTTLE (16571-828-09) · 16571-828-09

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →